{"title":"Blood Metabolites Mediate the Effects of Gut Microbiota on Diabetic Nephropathy: A Mendelian Randomization Study.","authors":"Weiwei Zhang, Yun Zhang, Huijuan Yuan","doi":"10.1155/ije/6642332","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The gut microbiota (GM) might be related to diabetic nephropathy (DN). The role of blood metabolites, immune cells, and plasma lipidomes in mediating the impact of GM on DN remains unexplored.</p><p><strong>Methods: </strong>412 GM, 1400 blood metabolites, 731 immune cells, 179 plasma lipidomes, and DN were identified through genome-wide association study (GWAS) datasets. We employed Mendelian randomization (MR) to investigate the relationship among GM, blood metabolomes, immune cells, plasma lipidomes, and DN. Furthermore, we conducted mediation analyses to ascertain if the blood metabolomes, immune cells, and plasma lipidomes function as mediators.</p><p><strong>Results: </strong>Our research identified suggestive causal linkages among 15 GM, 27 immune cells, 27 plasma lipidomes, and 55 blood metabolites associated with DN. Mediation analysis showed that advanced glycation end products (AGEs) pyrraline may mediate the causal relationship between s_Bacteroides_eggerthii and DN, with a mediation percentage of 39.96% (<i>p</i> = 0.015). Furthermore, immune cells and plasma lipidomes do not appear to play a mediating role.</p><p><strong>Conclusion: </strong>Gut microbiota, blood metabolomes, immune cells, and plasma lipidomes were causally linked to DN. The blood metabolite pyrraline may act as a potential mediator by which s_Bacteroides_eggerthii influences the risk of developing DN.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":"2026 ","pages":"6642332"},"PeriodicalIF":2.5000,"publicationDate":"2026-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13369588/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/ije/6642332","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The gut microbiota (GM) might be related to diabetic nephropathy (DN). The role of blood metabolites, immune cells, and plasma lipidomes in mediating the impact of GM on DN remains unexplored.
Methods: 412 GM, 1400 blood metabolites, 731 immune cells, 179 plasma lipidomes, and DN were identified through genome-wide association study (GWAS) datasets. We employed Mendelian randomization (MR) to investigate the relationship among GM, blood metabolomes, immune cells, plasma lipidomes, and DN. Furthermore, we conducted mediation analyses to ascertain if the blood metabolomes, immune cells, and plasma lipidomes function as mediators.
Results: Our research identified suggestive causal linkages among 15 GM, 27 immune cells, 27 plasma lipidomes, and 55 blood metabolites associated with DN. Mediation analysis showed that advanced glycation end products (AGEs) pyrraline may mediate the causal relationship between s_Bacteroides_eggerthii and DN, with a mediation percentage of 39.96% (p = 0.015). Furthermore, immune cells and plasma lipidomes do not appear to play a mediating role.
Conclusion: Gut microbiota, blood metabolomes, immune cells, and plasma lipidomes were causally linked to DN. The blood metabolite pyrraline may act as a potential mediator by which s_Bacteroides_eggerthii influences the risk of developing DN.
期刊介绍:
International Journal of Endocrinology is a peer-reviewed, Open Access journal that provides a forum for scientists and clinicians working in basic and translational research. The journal publishes original research articles, review articles, and clinical studies that provide insights into the endocrine system and its associated diseases at a genomic, molecular, biochemical and cellular level.